Dr. Mohammad Azhar Aziz, PhD

Cancer Research Scientist | Multi‑Omics, Precision & Personalized Medicine

Dr. Mohammad Azhar Aziz is an internationally trained cancer research scientist with over two decades of experience spanning India, the USA, and the Middle East. His research leadership is centered on multi‑omics integration, cancer nanomedicine, and precision oncology, with a strong translational focus aligned to national and global cancer priorities.

Currently at Aligarh Muslim University (AMU), Dr. Aziz serves as Founder Director of the Cancer Nanomedicine Consortium and has previously led the Interdisciplinary Nanotechnology Center, where he established cutting‑edge cancer nanotechnology and multi‑omics research programs. His vision emphasizes institution‑building, interdisciplinary collaboration, and capacity development, making AMU a growing hub for advanced cancer research.

Prior to returning to India, Dr. Aziz held senior scientific and leadership positions at the King Abdullah International Medical Research Center (KAIMRC), Saudi Arabia, where he founded and led the Colorectal Cancer Research Program. His work there involved managing large, clinician–scientist teams, setting up state‑of‑the‑art infrastructure, and successfully delivering outcomes across multiple competitively funded projects with high return on investment.

Dr. Aziz’s academic foundation includes a PhD in Biotechnology from Jawaharlal Nehru University, with postdoctoral training at Case Western Reserve University and The Cleveland Clinic (USA). His research portfolio spans cancer genomics and transcriptomics, alternative splicing biomarkers, nanomedicine‑enabled therapeutics, CRISPR/Cas9 delivery systems, and AI/ML‑driven precision oncology.

With 50+ peer‑reviewed publications, including high‑impact reviews and original research, edited books with Springer Nature, and substantial citation impact, Dr. Aziz is recognized globally for his scientific contributions. He serves on editorial boards of leading journals (Frontiers series, World Journal of Gastrointestinal Oncology) and as a reviewer for major funding agencies including the Department of Biotechnology, Government of India.

An award-winning scientist, he has received prestigious recognitions including the Annual Researcher Award from a leading healthcare system in Saudi Arabia and international accolades for innovation in biotechnology.

Dr. Aziz is deeply committed to training the next generation of researchers, having mentored PhD, postgraduate, and clinician‑scientists across continents. His work directly aligns with the priorities of Indian funding agencies (DBT, DST, CSIR, ICMR) as well as international sponsors, emphasizing innovation, translational impact, and global collaboration.

Dr. Aziz represents a strong asset for university‑led, fundable research programs in cancer biology, and precision medicine, with proven capability to deliver internationally competitive outcomes.